Xybion Digital Inc.

XYBN

CA98423T1093

Software

Market Closed - Toronto S.E. Other stock markets 09:48:58 2024-04-29 am EDT			5-day change	1st Jan Change
0.49 ^CAD	+8.89%		0.00%	-1.01%

Apr. 16	Envol Biomedical selects Xybion?s Preclinical Gold Standard LIMS, Pristima, to Digitize Lab Operations	CI
Feb. 23	Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023

February 22, 2024 at 06:30 pm EST

Xybion Digital Inc. reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was USD 4.76 million compared to USD 4.36 million a year ago. Net loss was USD 0.296928 million compared to USD 0.007105 million a year ago.
For the nine months, sales was USD 12.9 million compared to USD 12 million a year ago. Net income was USD 0.409109 million compared to net loss of USD 1.88 million a year ago.

Latest news about Xybion Digital Inc.

Envol Biomedical selects Xybion?s Preclinical Gold Standard LIMS, Pristima, to Digitize Lab Operations	Apr. 16	CI
Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 22	CI
Xybion Digital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 21	CI
Xybion Digital Closes Purchase of Autoscribe, US$15 Million Credit Facility	Nov. 16	MT
Xybion Digital Inc. Announces USD 15 Million Credit Facility	Nov. 16	CI
Xybion Digital Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-10-15	CI
Xybion Digital Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-10-15	CI
Deciphex and Xybion Digital Inc. Join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows	23-09-14	CI
Certara, Inc. and Xybion Digital Inc. Partner to Integrate Nonclinical R&D Software to Streamline Assessing Drug Safety & Efficacy	23-08-08	CI
Xybion to Streamline, Digitize and Optimize Stability Study Operations and Improve Compliance Using Labwise XD LIMS Platform	23-05-30	CI
Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-27	CI
Hubei Topgene Xingsheng Partners with Xybion Digital Inc. to Drive Medical Innovation Using Xybion Preclinical Solution, Pristima Xd	22-12-12	CI
Xybion Digital Maintained at Buy as FQ3 Results Come in Weaker than Expected; Price Target Lowered to C$3.15	22-11-30	MT
Xybion Digital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-28	CI
Xybion Digital Announced Proposed Financing of Up to $5 Million	22-10-04	MT
Xybion Digital Inc. Receives a Multi-Year, Multi-Million US Dollar Contract	22-09-27	CI
Xybion Digital Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-29	CI
Xybion Digital Inc. Enters into an Agreement for A 3-Year, USD 12.2 Million Credit Facility with National Bank of Canada	22-08-15	CI
Xybion Digital Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-25	CI
Xybion Digital Inc. Receives 5-Year Multi-Million US Dollar Contract with Leading Global Pharmaceutical Company Headquartered in Europe	22-03-22	CI
Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-15	CI
Stira Pharmaceuticals Selects Xybion Digital to Transform Lab Operations	22-01-26	CI
Xybion Digital Fiscal Second-Quarter Profit Nearly Triples on Higher Revenue	21-11-22	MT
Gravitas One Capital Corp. Reports Earnings Results for the Full Year Ended September 30, 2021	21-11-15	CI
Xybion Corporation completed the acquisition of Gravitas One Capital Corp. (TSXV:GONE.P) in a reverse merger transaction.	21-11-14	CI

Chart Xybion Digital Inc.

Duration

Period

More charts

Company Profile

Xybion Digital Inc. is a software as a service company, which digitizes drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a cloud platform. It offers solution through Pristima XD, Labwise XD, Xybion QMS, Emidence XD, and ECM XD. Its solutions focus on employee health and safety, integrated preclinical lab management, early-stage drug discovery, digital lab solutions, regulatory compliance, quality management, predictive compliance, content management, and systems validation. The Company help its customers with cloud-enabled Laboratory Information Management System (LIMS) software with embedded document management, data management, compliance, and safety modules. It serves industries, such as life sciences, healthcare and insurance, safety and workers comp, transportation, financial services, food and beverage, manufacturing, petrochemicals, radio pharmacy, biobanking, veterinary sciences, and materials and mining, among others.

Sector

Software

Calendar

2024-07-21 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Enterprise Software

	1st Jan change	Capi.
XYBION DIGITAL INC.	-1.01%	18.81M
ORACLE CORPORATION	+10.49%	320B
SAP SE	+22.90%	213B
SERVICENOW, INC.	+2.08%	148B
CONSTELLATION SOFTWARE INC.	+9.95%	56.08B
HUBSPOT, INC.	+9.58%	32.39B
FAIR ISAAC CORPORATION	-1.80%	28.25B
MICROSTRATEGY INCORPORATED	+104.71%	22.8B
WISETECH GLOBAL LIMITED	+23.11%	20.04B
SAGE GROUP PLC	-0.90%	14.59B